Abstract
Hypertension is one of the commonest causes of left ventricular hypertrophy and of congestive heart failure, at least amongst the adult population in westernized nations [1,2]. This strong association between elevated arterial pressure and heart disease has commonly been explained as a simple sequence of cardiac overload leading to myocardial hypertrophy and eventual failure. However, the spectrum of cardiac involvement by the hypertensive process is much wider than a pump response to an increased afterload [3] (Table 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib m: Role of blood pressure in the development of congestive heart failure. The Framingham Study. N Engl J Med 287: 781, 1972.
Kannel WB, Gordon T, Offutt D: Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Frmingham Study. Ann Int Med 71: 89, 1969.
Tarazi RC, Ferrario CM, Dustan HP: The heart in hypertension. In: Hypertension: Physiopathology and Treatment, p. 738. Genest J, Koiw E, Kuchel O, eds. New York: McGraw-Hill, 1976.
Friedberg CK: The heart in hypertension and renal disease. In: Diseases of the Heart, Philadelphia: W. B. Saunders, 1966.
Laird WP, Fixler DE: Left ventricular hypertrophy in adolescents with elevated blood pressure: Assessment by chest roentgenography, electrocardiography and echocardiogram. Pediatrics 67: 255–259, 1981.
Fouad FM, Nakashima Y, Tarazi RC, Salcedo E: Reversal of left ventricular hypertrophy with methyldopa. Am J Cardiol (in press).
Cohn JN: Blood pressure and cardiac performance. Am J Med 55: 351, 1973.
Nichols WW, Pepine CJ, Geiser EA, Conti CR: Vascular load defined by the aortic input impedance spectrum. Fed Proc 39 (2): 196, 1980.
Milnor WR: Arterial impedance as ventricular afterload. Circ Res 36: 565, 1975.
Tarazi RC, Magrini F, Dustan HP: The role of aortic distensibility in hypertension. In: Recent Advances in Hypertension, p. 133. Milliez P, Safar M, eds. Reims: Boehringer Ingelheim, 1975.
Katz AN: Physiology of the Heart, p. 250. New York: Raven Press, 1977.
Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Inves 56: 56, 1975.
Wilson JR, Teichek N, Hirshfeld J: Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med 68: 664, 1980.
Strauer BE: Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44: 999, 1979.
Ross J Jr, Sobel BE: Regulation of cardiac contraction. Ann Rev Physiol 34: 47, 1972.
Skelton CL, Sonnenblick EH: Heterogeneity of contractile function in cardiac hypertrophy. Circ Res (Suppl 2) 34, 35: 83, 1974.
Averill DB, Ferrario CM, Tarazi RC, Sen S, Bajbus R: Cardiac performance in rats with renal hypertension. Circ Res 38: 280, 1976.
Lund-Johansen P: Hemodynamic pattern in essential hypertension at rest and during muscular exercise. Acta Med Scand (Suppl 1 ) 181: 482, 1967.
Sen S, Tarazi RC, Bumpus FM: Biochemical changes associated with development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc Res 10: 254, 1976.
Gaasch WJ: Left ventricular radius to wall thickness ratio. Am J Cardiol 43: 1189, 1979.
Bugge-Asperheim B, Kiili F: Cardiac response to increased aortic pressure. Scand J Clin Lab Invest 24: 345, 1969.
Saragoca M, Tarazi RC: Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensve rat. Hypertension 3: 380, 1981.
Woodcock EA, Funder JW, Johnston CI: Decreased cardiac ß-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res 45: 560, 1979.
Saragoca M, Tarazi RC: Left ventricular hypertrophy in rats with renovascular hypertension: Alterations in cardiac function and adrenergic response. Hypertension 3 (Suppl II): 11–171, 1981.
Julius S, Esler M: Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol 36: 685, 1975.
Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL: Cardioadrenergic factor in essential hypertension. Am Heart J 88: 724, 1974.
Marcus ML, Mueller TM, Gascho JA, Kerber RE: Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol 44: 1023, 1979.
Mueller TM, Marcus ML, Kerber RE, Young JA, Barnes RW, Abboud FM: Effect of renal hypertension and left ventricular hypertrophy on the coronary circulation in dogs. Circ Res 42 (4): 543, 1978.
Bache RJ, Vrobel TR: Effects of exercise on blood flow in the hypertrophied heart. Am J Cardiol 44: 1029, 1979.
Wicker P, Tarazi RC: Coronary blood flow in renovascular hypertension: Changes during development and reversal of left ventricular hypertrophy. Eur Heart J (in press).
Pickering G: High Blood Pressure, pp. 351–355. New York: Grune & Stratton, 1968.
Sokolow M, Perloff D: The prognosis of essential hypertension treated conservatively. Circulation 23: 697, 1961.
Rodriguera E, Narang R, Ahmed S, Fiore JJ, Levinson GE: The significance of cardiomegaly by x-ray in hypertensive heart disease. Circulation 45, 46 (Suppl II): 104, 1972 (Abstract).
Tarazi RC, Miller A, Frohlich ED, Dustan HP: Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation 34: 818, 1966.
Gibson TC, Madry R, Grossman W, McLaurin LP, Craige E: The A-wave of the apexcardiogram and left ventricular diastolic stiffness. Circulation 49: 441, 1974.
Fouad FM, Tarazi Rc, Gallagher JH, Maclntyre WJ, Cook SA: Abnormal left ventricular relaxation in hypertensive patients. Clin Sci 59: 411s, 1980.
Dunn FG, Chandraratna PN, Basta LT, Frohlich ED: Pathophysiological assessment of hypertensive heart disease by echocardiography (ECHO). Am J Cardiol 39: 189, 1977.
Safar ME, Lehner JP, Vincent MI, Plainfosse MT, Simo ACh: Echocardiographic dimensions in borderline and sustained hypertension. Am J Cardiol 44: 930, 1979.
Richardson pj, Monaghan M: The role of echocardiography in the assessment of left ventricular hypertrophy in patients with hypertension. In: The Therapeutics of Hypertensions. The Royal Society of Medicine INternational Congress and Symposium Series No. 26, pp. 213–223. Royal Soc of Med (Lond), Academic Press (Lond), Grune & Stratton (New York), 1980.
Guazzi M, Fiorentini C, Olivari MT, Polese A: Cardiac load and function in hypertension. Am J Cardiol 44: 1007, 1979.
Ehrström: Enlargement of the heart in hypertension. Acta Med Scand 103 (Suppl 206): 86, 1946.
Grant RP: Aspects of cardiac hypertrophy. Am Heart J 46: 154, 1953.
Sen S, Tarazi RC, Khairallah PA, Bumpus Fm: Cardiac Hypertrophy in spontaneously hypertensive rats. Circ Res 35: 775, 1974.
Frohlich ED, Tarazi RC: Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 44: 459, 1979.
Raab W: Hormonal and nueorgenic cardiovascular disorders. Baltimore: Williams & Wilkins, 1953.
Tarazi RC, Sen S: Catecholamines and cardiac hypertrophy. In: Catecholamines and the Heart. Royal Society of Medicine International Congress and Symposium Series No. 8, p. 47. Mezey KC, Caldwell ADS, eds. Royal Society of Med (Lond), Academic Press (Lond), Grune & Stratton (New York), 1979.
Tarazi RC, Dustan HP, Bravo EL: The importance of plasma volume in the treatment of hypertension. In: Beta-Blockers: Present Status and Future Prospects, p. 102. Schweizer W, ed. Bern: Hans Huber, 1975.
Smith AJ: Clinical features of fluid retention complicating treatment with guanethidine. Circulation 31: 485, 1965.
Vogel JHK, Chidsey CA: Cardiac adrenergic activity in experimental heart failure assessed with beta-receptor blockade. Am J Cardiol 24: 198, 1969.
Chidsey CA, Braunwald AE, Monow AGL: Catecholamine excretion and cardiac stores of nerepinephrine in congestive heart failure. Am J Med 39: 442, 1965.
Tarazi RC, Dustan HP, Bravo EL: Haemodynamic effects of propranolol in hypertesnion: a review. Postgrad Med J 52 (Suppl 4): 92, 1976.
Guazzi M, Magrini F, Fiorentini C, Polese A: Role of the sympathetic nervous system in supporting cardiac function in essential arterial hypertension. Br Heart J 35: 55, 1973.
Alicandri C, Fouad FM, Tarasi RC, Bravo EL: Cardiac performance in hypertension. Circulation 55, 56 (SUPPL III): 28, 1977.
Tarazi RC: Effects of hypertension on the heart: pathophysiology and clinical implications. In: Hypertension: Determinants, Complications, and Interventions, pp. 211–224. Onesti G, Klimt CR, eds. New York: Grune & Stratton, 1979.
Hall O, Hall CE, Ogden E: Cardiac hypertrophy in experimental hypertension and its regression following reestablishment of normal blood pressure. Am J Physiol 174: 175, 1953.
Devereux RB, Savage DD, Sachs I, Laragh JH: Effect of blood pressure control on left ventricular hypertrophy and function in hypertension. Circulation 62 (Suppl II): 11–36, 1980 (Abstract).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Tarazi, R.C. (1982). Influence of Hypertension on the Heart. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_27
Download citation
DOI: https://doi.org/10.1007/978-94-009-7476-0_27
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7478-4
Online ISBN: 978-94-009-7476-0
eBook Packages: Springer Book Archive